Peptides and neurotransmitters that affect renin secretion
- PMID: 11540833
Peptides and neurotransmitters that affect renin secretion
Abstract
Substance P inhibits renin secretion. This polypeptide is a transmitter in primary afferent neurons and is released from the peripheral as well as the central portions of these neurons. It is present in afferent nerves from the kidneys. Neuropeptide Y, which is a cotransmitter with norepinephrine and epinephrine, is found in sympathetic neurons that are closely associated with and presumably innervate the juxtagolmerular cells. Its effect on renin secretion is unknown, but it produces renal vasoconstriction and natriuresis. Vasoactive intestinal polypeptide (VIP) is a cotransmitter with acetylocholine in cholinergic neurons, and this polypeptide stimulates renin secretion. We cannot find any evidence for its occurence in neurons in the kidneys, but various stimuli increase plasma VIP to levels comparable to those produced by doses of exogenous VIP which stimulated renin secretion. Neostigmine increases plasma VIP and plasma renin activity, and the VIP appears to be responsible for the increase in renin secretion, since the increase is not blocked by renal denervation or propranolol. Stimulation of various areas in the brain produces sympathetically mediated increases in plasma renin activity associated with increases in blood pressure. However, there is pharmacological evidence that the renin response can be separated from the blood pressure response. In anaesthetized dogs, drugs that increase central serotonergic discharge increase renin secretion without increasing blood pressure. In rats, activation of sertonergic neurons in the dorsal raphe nucleus increases renin secretion by a pathway that projects from this nucleus to the ventral hypothalamus, and from there to the kidneys via the sympathetic nervous system. The serotonin releasing drug parachloramphetamine also increases plasma VIP, but VIP does not appear to be the primary mediator of the renin response. There is preliminary evidence that the serotonergic neurons in the dorsal raphe nucleus are part of the pathway by which psychosocial stimuli increase renin secretion.
Similar articles
-
Neuropeptides in cardiovascular control.J Hypertens Suppl. 1984 Dec;2(3):S15-23. J Hypertens Suppl. 1984. PMID: 6400363 Review.
-
[Polypeptides and antagonists].Sem Hop. 1984 Mar 29;60(14):987-1002. Sem Hop. 1984. PMID: 6202006 Review. French.
-
Vasoactive intestinal peptide in the regulation of renin secretion.Am J Physiol. 1985 Jul;249(1 Pt 2):F84-9. doi: 10.1152/ajprenal.1985.249.1.F84. Am J Physiol. 1985. PMID: 3893159
-
The renin-angiotensin system and the central nervous system.Fed Proc. 1977 Apr;36(5):1771-5. Fed Proc. 1977. PMID: 191299 Review.
-
Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.J Pharmacol Exp Ther. 1981 Oct;219(1):85-90. J Pharmacol Exp Ther. 1981. PMID: 6457138
Cited by
-
Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: the influence of perindopril.J Endocrinol Invest. 1990 Jul-Aug;13(7):559-66. doi: 10.1007/BF03348625. J Endocrinol Invest. 1990. PMID: 2172356 Clinical Trial.
-
Vasoactive intestinal peptide.J Endocrinol Invest. 1986 Apr;9(2):191-200. doi: 10.1007/BF03348097. J Endocrinol Invest. 1986. PMID: 2872248 Review. No abstract available.
-
Inhibition of renin release by arachidonic acid metabolites, 12(s)-HPETE and 12-HETE: role of TRPV1 channels.Endocrinology. 2011 Oct;152(10):3811-9. doi: 10.1210/en.2011-0141. Epub 2011 Aug 16. Endocrinology. 2011. PMID: 21846804 Free PMC article.
-
Junctional transmission in renin-containing and smooth muscle cells of the afferent arteriole.Pflugers Arch. 1986 Jun;406(6):578-86. doi: 10.1007/BF00584024. Pflugers Arch. 1986. PMID: 3012458